1. Home
  2. DNLI vs CCU Comparison

DNLI vs CCU Comparison

Compare DNLI & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • CCU
  • Stock Information
  • Founded
  • DNLI 2013
  • CCU 1850
  • Country
  • DNLI United States
  • CCU Chile
  • Employees
  • DNLI N/A
  • CCU 9638
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • CCU Beverages (Production/Distribution)
  • Sector
  • DNLI Health Care
  • CCU Consumer Staples
  • Exchange
  • DNLI Nasdaq
  • CCU Nasdaq
  • Market Cap
  • DNLI 2.1B
  • CCU 2.5B
  • IPO Year
  • DNLI 2017
  • CCU 1992
  • Fundamental
  • Price
  • DNLI $13.89
  • CCU $12.51
  • Analyst Decision
  • DNLI Strong Buy
  • CCU Strong Sell
  • Analyst Count
  • DNLI 15
  • CCU 2
  • Target Price
  • DNLI $33.85
  • CCU $9.70
  • AVG Volume (30 Days)
  • DNLI 1.6M
  • CCU 136.2K
  • Earning Date
  • DNLI 07-31-2025
  • CCU 08-06-2025
  • Dividend Yield
  • DNLI N/A
  • CCU 3.66%
  • EPS Growth
  • DNLI N/A
  • CCU 67.38
  • EPS
  • DNLI N/A
  • CCU 0.47
  • Revenue
  • DNLI N/A
  • CCU $3,126,996,945.00
  • Revenue This Year
  • DNLI N/A
  • CCU $9.09
  • Revenue Next Year
  • DNLI $335.74
  • CCU $4.83
  • P/E Ratio
  • DNLI N/A
  • CCU $13.44
  • Revenue Growth
  • DNLI N/A
  • CCU 15.38
  • 52 Week Low
  • DNLI $10.57
  • CCU $10.00
  • 52 Week High
  • DNLI $33.33
  • CCU $15.75
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 45.02
  • CCU 23.48
  • Support Level
  • DNLI $14.19
  • CCU $13.11
  • Resistance Level
  • DNLI $14.88
  • CCU $13.29
  • Average True Range (ATR)
  • DNLI 0.77
  • CCU 0.28
  • MACD
  • DNLI -0.03
  • CCU -0.05
  • Stochastic Oscillator
  • DNLI 34.55
  • CCU 3.94

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: